Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated

British Journal of Pharmacology

Volumn 150, Issue 6, 2007, Pages 816-822

  Takahashi, H K ^a   Iwagaki, H ^a   Hamano, R ^a   Wake, H ^a   Kanke, T ^a   Liu, K ^a   Yoshino, T ^a   Tanaka, N ^a   Nishibori, M ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adenosine; Cytokine; Human peripheral blood mononuclear cells; Intercellular adhesion molecule 1; Interleukin 18

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); CYCLIC AMP; CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; LIGATION; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ADENOSINE; ADULT; AGED; CYTOKINES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; MALE; MIDDLE AGED; MONOCYTES; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947324677     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707126     Document Type: Article

References (25)

1. Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA (1994). Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 153: 4159-4168.
2. Bshesh K, Zhao B, Spight D, Biaggioni I, Feokistov I, Denenberg A et al. (2002). The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J Leukoc Biol 72: 1027-1036.
3. Camacho SA, Heath WR, Carbone FR, Sarvetnick N, LeBon A, Karlsson L et al. (2001). A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol 6: 523-529.
4. Cronstein BN, Levin RI, Philips MR, Hirschhorm R, Abramson SB, Weissmannn G (1992). Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148: 2201-2206.
5. Day YJ, Marshall MA, Huang L, McDuffie MJ, Okusa MD, Linden J (2004). Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol 286: G285-G293.
6. Gomez G, Sitkovsky MV (2003). Targeting G protein-coupled A2a adenosine receptors to engineer inflammation in vivo. Int J Biochem Cell Biol 35: 410-414.
7. Harada N, Okajima K, Murakami K, Usune S, Sato C, Ohshima K et al. (2000). Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J Pharmacol Exp Ther 294: 1034-1042.
8. Jacobson KA, van Galen PJM, Williams M (1992). Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem 35: 407-422.
9. Janeway Jr CA, Medzhitov R (2002). Innate immune recognition. Annu Rev Immunol 20: 197-216.
10. Karni A, Koldzic DN, Bharanidharan P, Khoury SJ, Weiner HL (2002). IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(p) T cells via CD40-CD40 ligand interactions. J Neuroimmunol 125: 134-140.
11. Khoa ND, Montesinos MC, Reiss AB, Delano D, Awadallah N, Cronstein BN (2001). Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human mono-Elenkov, I.J. (2000) Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol 164: 436-442.
12. Le Vraux V, Chen YL, Masson I, De Sousa M, Giroud JP, Florentin I, Chauvelot-Moachon L (1993). Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci 52: 1917-1924.
13. Link AA, Kino T, Worth JA, McGuire JL, Crane ML, Chrousos GP, Wilder RL, Elenkov IJ (2000). Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol 164: 436-442.
14. Marabito L, Montesinos MC, Schreibman DM, Balter L, Thompson L, Resta R et al. (1998). Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-59-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 2: 295-300.
15. Ohta A, Sitkovsky M (2001). Role of G protein-coupled adenosine receptors in down-regulation of inflammation and protection from tissue damage. Nature 414: 916-920.
16. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T et al. (1995). Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378: 88-91.
17. Poulsen SA, Quinn R (1998). Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem 6: 619-641.
18. Saha N, Moldovan F, Tardif G, Pelletier JP, Cloutier JM, Martel-Pelletier J (1999). Interleukin-1β-converting enzyme (caspase-1) in human osteoarthritic tissues. Localization and role in the maturation of interleukin-1β and interleukin-18. Arthritis Rheum 42: 1577-1587.
19. Spicuzza L, Bonfiglio C, Polosa R (2003). Research applications and implications of adenosine in diseased airways. Trends Pharmacol Sci 24: 409-413.
20. Takahashi HK, Iwagaki H, Tamura R, Xue D, Sano M, Mori S et al. (2003). Unique regulation profile of prostaglandin E1 on adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells. J Pharmacol Exp Ther 307: 1188-1195.
21. Takahashi HK, Iwagaki H, Yoshino T, Mori S, Morichika T, Itoh H et al. (2002). Prostaglandin E(2) inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells. J Immunol 168: 4446-4454.
22. Takahashi HK, Mori S, Iwagaki H, Yoshino T, Tanaka N, Weitz-Schmidt G et al. (2005). Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes. J Leukoc Biol 77: 400-407.
23. Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, Smith P et al. (2005). Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PloS Biol 3: 174.
24. Yamagata T, Ichinose M (2006). Agents against cytokine synthesis or receptors. Eur J Pharmacol 533: 289-301.
25. Zhang JG, Hepburn L, Cruz G, Borman RA, Clark KL (2005). The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes. Biochem Pharmacol 69: 883-889.